Direkt zum Inhalt
Merck
  • Impact of gestational bisphenol A on oxidative stress and free fatty acids: Human association and interspecies animal testing studies.

Impact of gestational bisphenol A on oxidative stress and free fatty acids: Human association and interspecies animal testing studies.

Endocrinology (2015-01-21)
Almudena Veiga-Lopez, Subramaniam Pennathur, Kurunthachalam Kannan, Heather B Patisaul, Dana C Dolinoy, Lixia Zeng, Vasantha Padmanabhan
ZUSAMMENFASSUNG

Bisphenol A (BPA) is a high production volume chemical and an endocrine disruptor. Developmental exposures to BPA have been linked to adult metabolic pathologies, but the pathways through which these disruptions occur remain unknown. This is a comprehensive interspecies association vs causal study to evaluate risks posed by prenatal BPA exposure and to facilitate discovery of biomarkers of relevance to BPA toxicity. Samples from human pregnancies during the first trimester and at term, as well as fetal and/or adult samples from prenatally BPA-treated sheep, rats, and mice, were collected to assess the impact of BPA on free fatty acid and oxidative stress dynamics. Mothers exposed to higher BPA during early to midpregnancy and their matching term cord samples displayed increased 3-nitrotyrosine (NY), a marker of nitrosative stress. Maternal samples had increased palmitic acid, which was positively correlated with NY. Sheep fetuses and adult sheep and rats prenatally exposed to a human-relevant exposure dose of BPA showed increased systemic nitrosative stress. The strongest effect of BPA on circulating free fatty acids was observed in adult mice in the absence of increased oxidative stress. This is the first multispecies study that combines human association and animal causal studies assessing the risk posed by prenatal BPA exposure to metabolic health. This study provides evidence of the induction of nitrosative stress by prenatal BPA in both the mother and fetus at time of birth and is thus supportive of the use of maternal NY as a biomarker for offspring health.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Hexan, ReagentPlus®, ≥99%
Sigma-Aldrich
Hexan, suitable for HPLC, ≥95%
Sigma-Aldrich
Hexan, Laboratory Reagent, ≥95%
Sigma-Aldrich
Hexan, HPLC Plus, for HPLC, GC, and residue analysis, ≥95%
Sigma-Aldrich
Palmitinsäure, ≥99%
Supelco
4,4′-Isopropylidendiphenol, ≥99%
Sigma-Aldrich
Palmitinsäure, BioXtra, ≥99%
Sigma-Aldrich
Palmitinsäure, ≥98%, FCC, FG
USP
Palmitinsäure, United States Pharmacopeia (USP) Reference Standard
Supelco
Hexan, analytical standard
Sigma-Aldrich
Palmitinsäure, ≥98% palmitic acid basis (GC)
Sigma-Aldrich
Palmitinsäure, natural, 98%, FG
Supelco
Palmitinsäure, analytical standard
Supelco
Palmitinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
DL-Tyrosin, 99%
Tyrosin, European Pharmacopoeia (EP) Reference Standard
Palmitinsäure, European Pharmacopoeia (EP) Reference Standard
Supelco
Palmitinsäure, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland